For Immediate Release
Media Contact: Scott Graf
scott.graf@ag.idaho.gov
(208) 334-4112

Date: December 16, 2016

Idahoans May be Eligible for Payment Under Recent Pharmaceutical Settlement

(Boise) - Idahoans who bought the wakefulness drug Provigil may be eligible for part of a $35 million settlement. Consumers who purchased generic versions may also be eligible.

Idaho Attorney General Lawrence Wasden announced in August a settlement with Cephalon, Inc. and its affiliated companies. The settlement included Idaho and 47 other states who filed a lawsuit asserting the manufacturer violated antitrust laws. Affected consumers could submit claims beginning this week.

Those who purchased Provigil® and/or generic versions of Provigil® (modafinil) between June 24, 2006 and March 31, 2012 may be entitled to a payment. To learn more about the settlement, and to submit a consumer claim form, consumers can now visit www.stateagprovigilsettlement.com. To be eligible to receive a payment, consumers must complete and submit a valid claim form by April 13, 2017.

- End -

News by Year:
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003